Success Story: Achieved Dual O-1A and EB1A Approvals for a Chief Scientific Officer from India without RFE
Client’s Testimonial:
“Chen knew exactly what data to request and executed immediately once I provided the letters and evidence. Their quality control was meticulous, spotting errors I missed to ensure the packet was flawless. That rigorous efficiency secured both my O1-A and EB-1A approvals without an RFE.”
On May 15th, 2025, and December 1st, 2025, we received another O-1A (Individuals with Extraordinary Ability or Achievement) and EB1A (Alien of Extraordinary Ability) approvals for a Chief Scientific Officer in the Field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Chief Scientific Officer
Country of Origin: India
State of Residence at the Time of Filing: California
Approval Notice Date: May 15th, 2025 & December 1st, 2025 (EB1A)
Processing Time: 7 days (O-1A), 24 days (EB1A) (Premium Processing Requested)
Case Summary:
“I strongly urge USCIS to approve [The Client ]’s application, as [The Client ]’s expertise and contributions are vital for the development of innovative therapies that will benefit countless patients.”
This statement reflects one of seven expert endorsements we secured for a chief scientific officer from India with a Ph.D. in Biomolecular Engineering. Our firm has had the privilege of supporting this exceptional client through two successful petitions: first, an I-129 O-1A petition approved in just 7 days, followed by an I-140 EB-1A petition approved in 24 days. Both petitions were filed under premium processing without RFE.
Our Strategic Approach:
As an expert in the field of bioinformatics, the client’s work focuses on computational protein modeling, protein design, and high-throughput experiments. We built a robust case emphasizing the client’s pioneering work in computational protein modeling and therapeutics design, with research transforming cancer treatment and drug discovery. Our petition strategically highlighted how this work advances critical U.S. national interests in biotechnology leadership and precision medicine.
We assembled powerful evidence of extraordinary ability:
- 21 peer-reviewed journal articles (2 first-authored and 4 co-first-authored), 5 abstracts (2 first-authored and 1 co-first-authored), and 1 granted patent
- 2,148 citations placing the client in the top 1% most highly cited authors
- 36 peer reviews for prestigious journals
- Competitive funding from the National Institutes of Health and the National Science Foundation
- Seven expert recommendation letters
Our petition also documented the client’s critical leadership role at a distinguished cancer research institute, where their work revolutionized approaches to protein degradation and cancer treatment.
The Result:
We are honored to have supported this remarkable researcher in securing recognition for their transformative contributions to bioinformatics. We extend our sincere best wishes for their continued success as they advance U.S. leadership in computational biology, targeted protein degradation, and next-generation cancer therapeutics.

